FRANKLIN RESOURCES INC

Position in KYMR — Kymera Therapeutics, Inc.

CIK 38777 San Mateo, CA

Position in KYMR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$59,060,781

+$28,928,793 QoQ

Shares Held

515,050

+42.4% QoQ

Ownership

0.619%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#29

of 273 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. KYMR ranks #31 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,771,839	$1,728,352,485
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,347,253	$1,662,680,977
3	ASND	Ascendis Pharma A/S	1,862,503	$496,766,798
4	JAZZ	Jazz Pharmaceuticals plc	2,040,250	$491,639,040
5	RVMD	Revolution Medicines, Inc.	1,488,394	$278,746,426
6	INSM	INSMED Inc	2,273,222	$242,370,927
7	LGND	Ligand Pharmaceuticals Inc	752,044	$237,713,585
8	ARGX	Argenx SE	224,930	$208,683,303

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$59,060,781	515,050	+42.4%	Shares	Defined	2026-08-13
2026-03-31	$30,131,988	361,772	+2.0%	Shares	Defined	2026-05-13
2025-12-31	$27,589,479	354,575	+1019.9%	Shares	Defined	2026-02-11
2025-09-30	$1,792,068	31,662	-5.9%	Shares	Defined	2025-11-13
2025-06-30	$1,468,441	33,649	+2.5%	Shares	Defined	2025-08-12
2025-03-31	$898,474	32,827	-14.4%	Shares	Defined	2025-05-13
2024-12-31	$1,543,502	38,367	+30.3%	Shares	Defined	2025-02-12
2024-09-30	$1,393,394	29,440	+35.1%	Shares	Defined	2024-11-27
2024-06-30	$650,520	21,793	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.